Lexeo Therapeutics, Inc.
SEC CIK 1907108 · LXEO · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cholmondeley Paula H | Director | filed 2023 - 2026 |
| Diaz Reinaldo M | Director | filed 2023 - 2026 |
| Altschuler Steven | Director | filed 2023 - 2026 |
| Agger Mette Kirstine | Director | filed 2023 - 2026 |
| Van Hauwermeiren Timothy | Director | filed 2024 - 2026 |
| Tanguler Tolga | Director | filed 2024 - 2026 |
| Cooperstone Brenda | Director | filed 2023 - 2026 |
| Townsend Richard Nolan | Director · Chief Executive Officer | filed 2023 - 2026 |
| Sepp-Lorenzino Laura | Director | filed 2026 - 2026 |
| Davitian Bernard | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Otero Jose Manuel | Chief Technical Officer | filed 2024 - 2026 |
| Bhalla Narinder Pal | Chief Medical Officer | filed 2026 - 2026 |
| Tamayo Louis Edward | Chief Financial Officer | filed 2025 - 2026 |
| Adler Eric | Chief Scientific Officer | filed 2023 - 2025 |
| Robertson Jenny | Chief Legal and Admin. Officer | filed 2023 - 2025 |
| See Tai Sandi | Chief Development Officer | filed 2024 - 2025 |
| Rasbach Kyle | Chief Financial Officer | filed 2024 - 2025 |
| Mccormac Paul | Chief Technical Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.